About Author : Pankaj Singh

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketing. Currently, he works for intelligencejournal.com, contributing insightful pieces across myriad professional domains.



Contribution by Pankaj Singh

EU, China ink deals to reinforce partnership on civil aviation safety

The agreements will enable passengers to benefit from safer, economical, and greener air travel options The European Union (EU) has reportedly signed two agreements on civil aviation with China that are aimed at creating jobs, boost growth and bring...

Read More >>
Cook Medical, Ambu A/S to jointly address endoscope-related infections

The two firms will bring forth single-use endoscopes to patients undergoing ERCP procedures to reduce the risk associated with serious cross-contaminations. Medical device company, Cook Medical Incorporated has recently agreed to enter into a partne...

Read More >>
Mastercard Lyft tie up to strengthen economic security of drivers

Mastercard, the financial services company announced an expanded partnership with a U.S. based transportation network company, Lyft, to bring tools to Lyft drivers for their growth in the ever-changing scenario of the gig economy. A bank account and...

Read More >>
SoftBank set to invest in the UK-based financing group Greensill

Softbank Vision Fund, the subsidiary of SoftBank Group Corp, is reportedly planning to invest in Greensill Capital, a UK based firm that specializes in supply chain finance. As per reliable sources, the investment will value Greensill at $3 billion,...

Read More >>
Cerevance successfully completes Phase 1 clinical trial of CVN424

Clinical stage biopharmaceutical company Cerevance has reportedly completed its Phase 1 clinical trial of CVN424, the company’s first-in-class, oral drug in development for treating Parkinson’s disease. The clinical study effectively atta...

Read More >>
EU CHMP recommends LYNPARZA as first-line treatment for ovarian cancer

AstraZeneca & Merck’s LYNPARZA has reportedly received a positive opinion from the EMA’s (European Medicine Agency) CHMP (Committee for Medicinal Products for Human Use), for the first-line maintenance treatment of the BRCA-mutated ad...

Read More >>
Apis Partners to invest in L&T IFD, aims for a 25% stake worth $110M

Apis Partners has signed a binding agreement for the acquisition of the stake and will be investing through one of its funds called Apis Growth Fund II. UK-based venture capital firm Apis Partners has reportedly announced plans to acquire a 25 per c...

Read More >>
Innovent doses first patient in bispecific antibody clinical trial

Innovent Biologics, Inc., a top-notch biopharmaceutical firm which produces and commercializes superior quality medications, has recently declared that the first patient has successfully been dosed in China in the Phase 1 trial of a recombinant compl...

Read More >>
U.K. approves inclusion of Huawei gear for 5G despite U.S. warnings

The National Security Council led by the Prime Minister agreed to give Huawei limited access to help build noncore infrastructure for the network Reports confirm that U.K. has dismissed warnings of the U.S. about including 5G telecoms equipment from...

Read More >>
Social media platforms blocked in Sri Lanka in the aftermath of blasts

The government has decided to temporarily block Facebook, Instagram, and other social media sites for restricting the spread of false news The government of Sri Lanka has reportedly announced the temporary blocking of various social media services a...

Read More >>
Amazon in talks for ad-supported music service to compete with Spotify

Amazon is planning to market its free music streaming service through its Alexa-powered Echo smart speakers Amazon.com is reportedly in discussions to launch its own ad-supported music service offering, which can help strengthen the competition with...

Read More >>
Regeneron Alnylam collaborate on a $1bn eye & CNS R&D agreement

Regeneron Pharmaceuticals Inc. and Alnylam Pharmaceuticals Inc. have reportedly entered into a definitive collaborative deal. Authentic sources claim that the deal has been inked in a major effort to discover, advance and commercialize treatments for...

Read More >>
Google adjourns AI ethics board following protests & online petition

An online petition had called on Google to single out Kay Coles James (Heritage Foundation) from the council that was formed a week ago. Technology giant Google has confirmed the dissolution of its recently formed AI ethics advisory panel on the gro...

Read More >>
Crypto exchange platform Liquid hits $1B valuation with new funding

·         Liquid will use the capital for offering new services and expanding into new markets ·         The firm has said that it is publicly in favour of...

Read More >>
Avaya deliberating over leveraged buyout offer that values it at $5Bn

The proposed acquisition offer comes approximately 15 months after the company emerged from a bankruptcy protection.   The company has been attracting acquisition interest from several private equity companies over the previous couple of mon...

Read More >>
Teladoc Health announces acquisition of France-based MedecinDirect

The deal is expected to be closed in first half of this year   Financial terms of the deal were not disclosed yet Virtual care provider Teladoc Health has announced that it has acquired France-based telemedicine provider MédecinDire...

Read More >>
Mercado Libre bans crypto-related listings following PayPal Investment

The Latin American e-commerce firm had recently obtained a $750 million investment from PayPal. The company is also cracking down upon pre-paid cards that are typically used for games. Mercado Libre, Inc., (Mercado Libre), a renowned Argentine e...

Read More >>
FDA approves new generic valsartan to reduce the shortage of drug

The regulator reviewed the manufacturing and testing practices of India-based Alkem Laboratories Limited and found no traces of impurity The United States Food and Drug Administration (FDA) has reportedly announced to have approved a new generic ver...

Read More >>
Wayland, International Cannabis in talks to sign a purchase agreement

Both the companies are nearing conclusion of their strategic reviews and expecting to enter into a definitive purchase agreement   The companies are expecting to realize material synergies, which would result in accelerated revenues along wi...

Read More >>
Akili & Shionogi partnership to bring new digital therapeutics to Asia

The new strategic partnership would see the two enterprises collaborate on the development & commercialization of digital therapeutics in crucial Asian markets.   Potential & upfront milestone payments to Akili for the Taiwan & J...

Read More >>
SoftBank plans to invest $10m in Swedish solar technology firm Exeger

SB Energy Corp will be supporting the global rollout process of Exeger’s technology and products SoftBank Group will hold the right to nominate a director for being appointed on Exeger’s board SoftBank Group, the Japanese multinational ...

Read More >>
German logistics service provider FlixBus to take over rival Eurolines

FlixBus will integrate the long-distance routes of Eurolines and isilines to expand European reach The company aims to entice more passengers by offering more complete and diverse services FlixBus, the Germany-based bus logistics start-up backed by...

Read More >>
Emergent BioSolutions to supply medical countermeasures to US

The company would manufacture and deliver several medical countermeasures prescribed by the Department of State including auto-injector training devices, Reactive Skin Decontamination Lotion Kit, and the Trobigard auto-injector Emergent BioSolutions...

Read More >>
Atara Biotherapeutics to present clinical results of Car T platform

The firm is looking forward to its MSK collaborators’ clinical outcomes of a mesothelin-targeted autologous CAR T for patients suffering from advanced malignant pleural ailment   The event is slated to be held from March 29 to April 3 ...

Read More >>
GNA & Boehringer collaborate on ASF diagnostic test development

Both the companies will come up with holistic solutions for farmers, veterinarians, and the food producing industry. The partnership aims to develop a diagnostic test for ASF. Research-driven pharma conglomerate Boehringer Ingelheim has joined f...

Read More >>
Indivior introduces generic version of its Suboxone opioid drug

The company said its launch of an authorize generic version of the drug would prompt other firms to introduce their own cheaper versions The announcement comes in backdrop of a court ruling that allowed its rivals to sell generic versions of the d...

Read More >>
Britain claims risk in using Huaweis 5G equipment can be mitigated

Huawei was accused of working with China’s government by the U.S., who said its equipment can be used to spy on Americans The National Cyber Security Centre (NCSC) of Britain has reportedly concluded that the British government would be able t...

Read More >>
ElaadNL comes up with a PoC for IOTA-driven smart power grid for EVs

The PoC apparently depicts the ability of smart grids to generate and consumer power, and then redistribute the same autonomously among community members. The reputed Dutch technology conglomerate ElaadNL has made it to the front page for apparently...

Read More >>
Autonomous truck enterprise TuSimple raises almost $100M in Series D

TuSimple will use the funding to expand its self-driving truck fleet. Renowned self-driving truck company TuSimple has made it to the headlines for having successfully raised substantial capital in a new funding round. As per credible reports, the s...

Read More >>
Symantec acquires Luminate in an effort to peruse cloud security

Luminate’s ‘Secure Access Cloud™ ‘ further extends Symantec’s ‘Integrated Cyber Defense Platform’ expertise to users. Renowned California-based software magnate Symantec Corp has made it to the headlines for...

Read More >>